Cineworld’s share price looks dirt-cheap! Should I buy in?

Cineworld’s share price trades well below a P/E ratio of 10 times. Does this make the UK share an unmissable bargain or just an investment trap?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Is Cineworld Group (LSE: CINE) one of the most dangerous shares out there? I sold my holdings in the UK leisure stock just over a year ago. And while Cineworld’s share price rallied at the end of 2020 and the start of 2021, the risks facing the business remain severe.

Latest Covid-19 infection figures in Cineworld’s core markets make for gruesome reading. Soaring cases of the Omicron variant mean infection numbers hit record peaks of 129,471 in the firm’s home UK market on Tuesday. At the same time, cases in Cineworld’s core US marketplace reached new peaks of 512,553.

In this climate the prospect that cinemas will have to close their doors again is very real. But even if Cineworld’s theatres aren’t shuttered, other rules could have a significant impact on the number of people going to the movies.

The requirement for masks to be worn could discourage people from attending in large numbers. Proof of vaccination for people entering all entertainment venues is something else that could smack ticket sales at Cineworld. The latter rule is already in force in some parts of the US.

Debt problems

I divested my Cineworld shares last year as its debts mounted and Covid-19 closed its cinemas. Unhappily both of these problems remain very high risks right now. Much has been made of the company’s net debt mountain in particular, which stood at $8.4bn as of June.

To add to Cineworld’s woes last month, it lost a legal case over its aborted purchase of Canada’s Cineplex cinema house. It’s been ordered to pay a whopping £725m in damages and lost transaction costs. It wouldn’t be a shock to see beleaguered Cineworld slap more debt on the pile or raise cash by tapping shareholders to keep its head above water.

Cineworld’s share price: worth the gamble?

Cineworld’s share price plunged to its cheapest since November 2020 following mid-December’s ruling around 27p. And while it’s recovered some ground to 32p, I wouldn’t be shocked to see it plunge again.

Things aren’t all bad for Cineworld, however. Bubbly box office sales in recent months show that the cinema has lost none of its allure despite the ongoing pandemic. Marvel’s latest superhero flick Spider-Man: No Way Home generated a jaw-dropping $260.1m in the US and Canada in its opening weekend earlier this month. That’s the second-biggest opening weekend in cinema history and follows a string of other highly successful theatre releases in 2021.

Cineworld’s share price looks mega-cheap right now. The penny stock trades on a P/E ratio of just 8.9 times for 2022. It packs a meaty 4.8% dividend yield for the new year, too. But despite these attractive numbers I won’t be buying in: Cineworld’s shares are cheap for a reason. I wouldn’t be surprised to see Cineworld’s share price fall all the way to 0p. So I’d much rather buy other cheap UK shares for my portfolio today.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »